JPS59110616A - Poultice - Google Patents
PoulticeInfo
- Publication number
- JPS59110616A JPS59110616A JP22158882A JP22158882A JPS59110616A JP S59110616 A JPS59110616 A JP S59110616A JP 22158882 A JP22158882 A JP 22158882A JP 22158882 A JP22158882 A JP 22158882A JP S59110616 A JPS59110616 A JP S59110616A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- poultice
- water
- plaster
- soluble polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims abstract description 30
- 230000002378 acidificating effect Effects 0.000 claims abstract description 14
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 13
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 12
- 238000004132 cross linking Methods 0.000 claims abstract description 10
- 239000011505 plaster Substances 0.000 claims abstract description 10
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 8
- 229920000159 gelatin Polymers 0.000 claims abstract description 7
- 239000008273 gelatin Substances 0.000 claims abstract description 7
- 108010010803 Gelatin Proteins 0.000 claims abstract description 6
- 235000019322 gelatine Nutrition 0.000 claims abstract description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 3
- 239000001913 cellulose Substances 0.000 claims abstract description 3
- 229920002678 cellulose Polymers 0.000 claims abstract description 3
- 235000010980 cellulose Nutrition 0.000 claims abstract description 3
- 229920001577 copolymer Polymers 0.000 claims abstract description 3
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 3
- 235000010443 alginic acid Nutrition 0.000 claims abstract 2
- 229920000615 alginic acid Polymers 0.000 claims abstract 2
- 239000001814 pectin Substances 0.000 claims abstract 2
- 235000010987 pectin Nutrition 0.000 claims abstract 2
- 229920001277 pectin Polymers 0.000 claims abstract 2
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 12
- 229920000058 polyacrylate Polymers 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 239000004020 conductor Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 229910052782 aluminium Chemical class 0.000 abstract description 5
- 238000007665 sagging Methods 0.000 abstract description 4
- 229910052742 iron Inorganic materials 0.000 abstract description 2
- 229910052749 magnesium Inorganic materials 0.000 abstract description 2
- 150000001455 metallic ions Chemical class 0.000 abstract 3
- 239000000783 alginic acid Substances 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 12
- -1 At5+ Chemical compound 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 8
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 235000008429 bread Nutrition 0.000 description 4
- 229960000846 camphor Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960002389 glycol salicylate Drugs 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 239000005995 Aluminium silicate Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 3
- 239000000920 calcium hydroxide Substances 0.000 description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 150000003902 salicylic acid esters Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- AMZWNNKNOQSBOP-UHFFFAOYSA-M [n'-(2,5-dioxoimidazolidin-4-yl)carbamimidoyl]oxyaluminum;dihydrate Chemical compound O.O.NC(=O)NC1N=C(O[Al])NC1=O AMZWNNKNOQSBOP-UHFFFAOYSA-M 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- JHECKPXUCKQCSH-UHFFFAOYSA-J calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;hydrate Chemical compound O.[Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O JHECKPXUCKQCSH-UHFFFAOYSA-J 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229920005614 potassium polyacrylate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- CVNKFOIOZXAFBO-UHFFFAOYSA-J tin(4+);tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Sn+4] CVNKFOIOZXAFBO-UHFFFAOYSA-J 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、支持体に対する膏体のしみ出しく裏じみ)が
なく、保型性、保水性に優れ、粘系性〃二高いと共に、
有効成分安定性に優れ、皮膚刺激の緩和された酸性の湿
布剤に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention has no oozing of the paste onto the support, excellent shape retention and water retention, high viscosity, and
This invention relates to an acidic poultice with excellent active ingredient stability and reduced skin irritation.
従来の湿布剤は、カオリン、セ゛ラテン、クリセリンを
ベークにし、これに他の水溶性高分子物a1例えはポリ
アクリル酸ソーダ、ポリビニルアルコ−ル
分などを加えて練合してペーヌト状とし、これを支持体
に塗布したもので、そのままでは、熱や汗争で膏体がブ
レ易いため、これを多価金属イメ゛ンで架橋させたり(
特り:1昭53−15413、同54−17113、戸
,154−26326、iEi 5 4−92618!
4)、尿素を加えて尿素−ゼラチンコンブレックヌを形
成したり(特開昭45−5278、同45−12314
等)、ノー7 p− = e )’ rンプン等の有鰻
7,i5箇剤で架橋ゲル化さ一゛Zたり(特] −
1昭 51−91318 、 16ノ 51−
101L19 、同5 1 − 1 0 4 0 2
7、■]52.−143223、同54−14351
7等)、高分子−高分子コンプレックス形成による不溶
化を行なったり(特開昭52−38016)などして耐
熱性、耐水性を高め、ダレを防止しているものである。Conventional poultices are made by baking kaolin, ceratene, and chrycerin, adding other water-soluble polymers such as sodium polyacrylate, polyvinyl alcohol, etc., and kneading the mixture to form a paste. is applied to a support, and if left as is, the paste tends to shake due to heat and sweat, so it is cross-linked with a polyvalent metal image (
Particularly: 1 1973-15413, 1971-17113, Door, 154-26326, iEi 5 4-92618!
4) Adding urea to form a urea-gelatin combination (JP-A-45-5278, JP-A-45-12314)
etc.), No. 7 p- = e)' R, etc., which can be cross-linked and gelled with 7, i5 ingredients (special) -
1 Showa 51-91318, 16No 51-
101L19, 5 1 - 1 0 4 0 2
7,■]52. -143223, 54-14351
7), insolubilization by forming a polymer-polymer complex (Japanese Patent Laid-Open No. 52-38016), etc., to improve heat resistance and water resistance and prevent sagging.
しかし、従来の湿布剤膏体ばPHが6以上、通常7〜9
であるため、サルチル酸エステル類等の有効成分の安定
性が悪く、また皮膚刺激性を有する等の問題がある。こ
のため、酸性の膏体が望1れるが、従来の湿布剤では、
有効成分安定化や皮膚刺激緩和等のために酒石酸、クエ
ン酸等の有機酸又は塩酸等の鉱酸を加えてPHを下げて
酸性にすると、配合高分子物質(特にゼラチンやアニオ
ン性高分子物質)の粘度が著しく低下してダレや裏じみ
を生じ、従って酸性の湿布剤においてはダレを防止する
ためによほどしっかりと架橋グル化ネせなければ〃らな
いが、従来技術ではPH6以下にするとノアルデヒドデ
ンゾンや尿素は反応が進行せず、金属架橋では架橋効果
が少なかったシ、架橋剤を加えれば加えるほど膏体自身
は硬くなるが、裏じみはかえって多く生じることがあシ
、酸性の湿布剤を得ることは極めて困難であった。However, conventional poultices have a pH of 6 or higher, usually 7 to 9.
Therefore, there are problems such as poor stability of active ingredients such as salicylic acid esters and skin irritation. For this reason, acidic plasters are desirable, but conventional poultices
Adding organic acids such as tartaric acid and citric acid or mineral acids such as hydrochloric acid to lower the pH and make it acidic in order to stabilize the active ingredient and alleviate skin irritation, etc. ) decreases significantly, causing sag and bleed. Therefore, in acidic poultices, it is necessary to thoroughly crosslink and glue to prevent sagging, but with conventional technology, when the pH is lower than 6, With noaldehyde denzone and urea, the reaction did not proceed, and with metal crosslinking, the crosslinking effect was small. It was extremely difficult to obtain a poultice.
本発明者らは、上記事情に鑑み、裏じみがなく、保水性
、保型性に優れ、かつ粘着力が強いと共に、有効成分安
定性が高く、シかも皮膚刺激の緩和された酸性膏体の湿
布剤を得るために鋭意研究を行なった結果、ポリアクリ
ル酸及び/又はポリアク物質を含有するPH3,5〜6
の湿布剤において、架橋化剤として金属イオン種の異な
る2行以上の多価金属塩を併用し、それぞれの高flに
対し別々に架橋を行なうことにより、上記目的が効果的
に達成されることを知見した。即ち、例えばカルボキシ
メテルセルローヌはCr 、 Ag 、 Fe””
十、3+
Pb2+、At5+、Ba 2+、Sn2+イオンとは
架橋ダル化するが、Ca2+、Mg2+、Mn2+とけ
架橋グル化せず、他方ポリアクリル酸ソーダはCa2+
、Mg2+と架橋グル化するものであシ、またA7”
、Ba2人Fe2+13+ハカルポキシメチルセルロー
ス、辿りアクリル酸ソーダ共に架橋ダル化するが、酸性
領域では圧倒的にカルボキシメチル七ルロースとの反応
が起り易く、従ってカルゴキシメチルセルローヌーポリ
アクリル酸ソーダ混合系に例えばAt3+イオンとCa
2+イオンを加えると、At5+イオンに対してはカル
ブキシメチルセルロースのみが架橋反応にあずかり、ポ
リアクリル酸ソーダは事実上At3+イオンと反応せず
、ポリアクリル酸ソーダはCa2+イオンによって架橋
される結果となるもので、本発明者らはこのように金属
イオンがを2錘以上組合せることにより、配合された釉
々の高分子物質の架橋が完全となり、酸性領域でもダレ
や裏じ皐のない優れた特性の酸性湿布剤が得られること
を知見し、本発明をなすに至ったものである。In view of the above circumstances, the present inventors have developed an acidic plaster that does not bleed, has excellent water retention and shape retention, has strong adhesive strength, has high stability of active ingredients, and has reduced skin irritation. As a result of intensive research to obtain a poultice with a pH of 3.5 to 6 containing polyacrylic acid and/or polyac material,
In this poultice, the above objective is effectively achieved by using two or more lines of polyvalent metal salts with different metal ion types as crosslinking agents, and crosslinking each high fl separately. I found out. That is, for example, carboxymethel cellulone contains Cr, Ag, Fe""
10,3+ Pb2+, At5+, Ba2+, and Sn2+ ions cross-link and dull, but Ca2+, Mg2+, and Mn2+ do not cross-link and glugate, while sodium polyacrylate does not cross-link with Ca2+.
, which cross-links with Mg2+, and also A7"
, Ba2Fe2+13+ hacarpoxymethylcellulose and sodium acrylate are both crosslinked and dulled, but in the acidic region, the reaction with carboxymethyl heptylulose is overwhelmingly likely to occur, so for example in the carboxymethylcellulone-sodium polyacrylate mixed system. At3+ ions and Ca
When 2+ ions are added, only carboxymethyl cellulose participates in the crosslinking reaction with At5+ ions, sodium polyacrylate virtually does not react with At3+ ions, and sodium polyacrylate is crosslinked by Ca2+ ions. By combining two or more metal ions in this way, the present inventors achieved complete crosslinking of the blended polymeric material of the glaze, resulting in an excellent product that does not sag or crease even in acidic areas. It was discovered that a characteristic acidic poultice can be obtained, and this led to the present invention.
以下、本発明につき更に詳しく説明する。The present invention will be explained in more detail below.
本発明の湿布剤は、膏体がp)13.5〜6の酸性であ
り、かつぼりアクリル酸及び/又はポリアクリル酸塩と
これと異なる他の水溶性高分子物aとを互に異なる金属
イオン種を有する多価金属塩で架橋させてなることを特
徴とするものである。In the poultice of the present invention, the plaster is acidic with p) 13.5 to 6, and the acrylic acid and/or polyacrylate and the other water-soluble polymer a are different from each other. It is characterized by being crosslinked with a polyvalent metal salt having metal ion species.
この場合、本発明においてポリアクリル酸の種類に特に
制限はなく、直鎖状、分枝状又は架橋タイプで種々の分
子量のものを用いることができる。In this case, the type of polyacrylic acid is not particularly limited in the present invention, and polyacrylic acids of linear, branched, or crosslinked types with various molecular weights can be used.
具体的には市販品としてジ=リマーAC−10H%AC
−10SH,ジンロンPW−110,111(いずれも
日本紬薬社製)、アロンA−10H(東亜合成社製)等
が好適に使用される。1だ、ポリアクリル酸塩としては
いずれの塩も使用できるが、特にポリアクリル酸ソーダ
、ポリアクリルしカリウム、ポリアクリル酸アルカノー
ルアミン等が好適に用いられ、市販品としてはアロンビ
ヌSX SS、GLXM(日本紬薬社製)、ビヌコメー
)P−480、F−480、F−460(昭和電工社製
)、アロンA−20P、、A−20PG。Specifically, as a commercially available product, Di-Limer AC-10H%AC
-10SH, Jinron PW-110, 111 (all manufactured by Nippon Tsumugi Pharmaceutical Co., Ltd.), Aron A-10H (manufactured by Toagosei Co., Ltd.), and the like are preferably used. 1. Any salt can be used as the polyacrylate, but sodium polyacrylate, potassium polyacrylate, alkanolamine polyacrylate, etc. are particularly preferably used, and commercially available products include Alonbinu SX SS, GLXM ( Nippon Tsumugi Pharmaceutical Co., Ltd.), Binukome) P-480, F-480, F-460 (Showa Denko Co., Ltd.), Aron A-20P, A-20PG.
A−20PH(東亜合成社製)等が使用できる。A-20PH (manufactured by Toagosei Co., Ltd.) etc. can be used.
なお、ポリアクリル酸、ノリアクリル酸塩の配合部は湿
布側膏体全体の0.5〜20係(重量係、以下同じ)、
特に1〜10係とすることが好ましく、0.5係より少
ないと十分な粘度が得られず、保型性が低下してダレの
原因となp、20%よシ多いと粘度が高くなりすぎ、練
合、塗布等の作業性が低下する場合が生じる。また、ポ
リアクリル酸とポリアクリル酸塩とを併用する場合、そ
の配合比(重量比)は9:1〜3ニアとすることが好壕
しく、ポリアクリル酸塩が少なすぎるとPHが3.5よ
り低くなり、逆に多すぎるとPHが6より高くなる場合
が生じる。In addition, the blending portion of polyacrylic acid and noryacrylate is 0.5 to 20 parts (by weight, the same applies hereinafter) of the entire compress side plaster.
In particular, it is preferable to set the ratio to 1 to 10. If it is less than 0.5, sufficient viscosity will not be obtained and the shape retention will decrease, causing sagging. If it is more than 20%, the viscosity will increase. Workability such as rinsing, kneading, and coating may be reduced. In addition, when polyacrylic acid and polyacrylate are used together, it is preferable that the blending ratio (weight ratio) is 9:1 to 3. If the polyacrylate is too small, the pH will be 3. If the amount is too high, the pH may become higher than 6.
クチン、アルギン酸ソーダ、カルボキシメチルセルロー
ス、ホリビニルアルコール、メチルビニルエーテル・無
水マレイン酸共重合体等から選はれる1種又は2種以上
のものが好適に用いられる。One or more selected from cutin, sodium alginate, carboxymethyl cellulose, vinyl alcohol, methyl vinyl ether/maleic anhydride copolymer, etc. are preferably used.
この場合、水溶性高分子物質の配合量は湿布剤膏体全体
の1〜15係、特に1〜10係とすることが好まし、く
、1係より少ないと粘度が不足して保型性が保てず、1
5係より多いと粘度が高くなり、練合時及び塗布時の作
業性が低下する場合がある。In this case, it is preferable that the amount of the water-soluble polymer substance is 1 to 15 parts, especially 1 to 10 parts, of the entire poultice.If it is less than 1 part, the viscosity will be insufficient and the shape retention will be cannot be maintained, 1
When the amount is more than 5, the viscosity becomes high and workability during kneading and coating may decrease.
本発明は、上記水溶性高分子物質を含有する湿布剤にお
いて、架橋化剤としてポリアクリル酸及び/又はぼりア
クリル酸塩を架橋化する多価金属塩と、この多価金属塩
と金属イオン鍾が異なり、前記ポリアクリル酸及びポリ
アクリル酸塩以外の水溶性高分子物質(カルボキシメチ
ルセルロース、ゼラチン等)を架橋化する1が又は2種
以上の多価金属塩とを併用してなるもので、この場合前
者としてばCa塩、Mg @等が、後者としてはAt場
、Fe塩(Fe2+、Fe5 + )、Sn塩(Sn4
+、Sn2+)等が特に好適に用いられる。なお、これ
ら多価金属塩は水に可溶、微溶、ile溶のいずれのも
のでもよく、具体的には塩化カルシウム、塩化マグネシ
ウム、塩化アルミニウム、カリ明パン、アンモニウム明
パン、鉄門パン、硫酸アルミニウム、硫酸第2鉄、硫酸
マグネシウム、EDTA−カルシウム、EDTA −ア
ルミニウム、EDTA−マグネシウム、塩化第1錫、塩
化第2錫等の可溶性塩、水酸化カルシウム、水酸化第2
鉄、水酸化アルミニウム、炭酸カルシウム、炭酸マグネ
シウム、リン酸カルシウム、ステアリン酸マグネシウム
、ヌテアリン酸アルミニウム、クエ、ン酸カルシウム、
硫酸バリウム、水酸化バリウム、アルミニウムアラント
イネート、酢酸アルミニウム、アルミニウムダリシナー
ル、水酸化第1錫、正錫酸、α−錫酸等の微溶性又は難
溶性塩などから選ばれる2種以上を併用できる。1だ、
その合計配合量は湿布剤膏体全体のO,OO5〜10係
、特に0.01〜5係とすることが好ましく、0.00
5%より少ないと架橋効果が十分得られず、ダレの度、
因となり、10壬より多いと膏体が硬くなりすぎ、肌へ
の密着性が低下し、時には離水する場合が生じる。The present invention provides a poultice containing the above-mentioned water-soluble polymeric substance, which includes a polyvalent metal salt for crosslinking polyacrylic acid and/or polyacrylate as a crosslinking agent, and a combination of this polyvalent metal salt and a metal ion. 1 or 2 or more polyvalent metal salts are used in combination to crosslink water-soluble polymer substances (carboxymethyl cellulose, gelatin, etc.) other than the polyacrylic acid and polyacrylate, and In this case, the former is Ca salt, Mg@, etc., and the latter is At field, Fe salt (Fe2+, Fe5 +), Sn salt (Sn4
+, Sn2+), etc. are particularly preferably used. Note that these polyvalent metal salts may be soluble, slightly soluble, or ile-soluble in water, and specifically include calcium chloride, magnesium chloride, aluminum chloride, potash light bread, ammonium light bread, ironmon bread, Soluble salts such as aluminum sulfate, ferric sulfate, magnesium sulfate, EDTA-calcium, EDTA-aluminum, EDTA-magnesium, stannous chloride, stannic chloride, calcium hydroxide, dibasic hydroxide
Iron, aluminum hydroxide, calcium carbonate, magnesium carbonate, calcium phosphate, magnesium stearate, aluminum nateate, quench, calcium phosphate,
A combination of two or more selected from slightly soluble or sparingly soluble salts such as barium sulfate, barium hydroxide, aluminum allantoinate, aluminum acetate, aluminum dalicinal, stannous hydroxide, orstannic acid, α-stannic acid, etc. can. It's 1.
The total blending amount is preferably 5 to 10 parts, particularly 0.01 to 5 parts, O, OO of the entire poultice, and 0.00 parts.
If it is less than 5%, a sufficient crosslinking effect cannot be obtained, resulting in sag,
If the amount is more than 10 tsumu, the paste becomes too hard, resulting in poor adhesion to the skin and sometimes causing water separation.
本発明の湿布剤は、上記各成分をその他の適宜な成分と
共によく練合してベーヌト状に調製するもので、このよ
うにして得られた溝布剤は紙、織布、不織布、プラヌテ
ックフイルム等の支持体(バッキング)に塗布し、必要
によりポリエチレンフィルム等のフエイシングを被覆し
て使用するものである〇
なお、本発明の他の成分としては、通常使用される適宜
な成分が用いられ、例えばプロピレングリコール、ポリ
エチレングリコール、グリセリン、ソルビトール等の1
種又は2種以上の多価アルコール(配合14°通常膏体
全体の5〜60係。5係より少ないと保湿効果が不足し
、また上限に特にナイト、モンモリロナイト、酸化亜鉛
、酸化チタン、無水ケイ酸等の1種又は2稙以上の無機
粉体(配合量通常O〜30%。30係より多いと膏体が
硬くなりすぎ、肌へのフィツト感や粘着力が低$e)、
水(配合量通常10〜80係。10酸メチル、ザルチル
酸グリコール、インドメタシン、t−メントール、)・
ツカ油、ユーカリ油、dt−カンフル、トウガラシエキ
ヌ、ノニル酸ワニリルアミド、ビタミンE1 ジフェン
ヒドラミン、マレイン酸クロルフェニラミン、チモール
等01秒又は2種以上の有効成分(配合量通常O〜20
係)、更に膏体物性(柔軟性、粘着性、保型性等)のp
[剤としてグアがム、キサンタンガム、アラビアガム、
デンプン誘導体、ポリブテン、ラテツクヌ、酢酸ビニル
エマルシコン、y りIJ ル’M脂エマルション等の
窩分子物質、有効成分の安定配合要に応じ適宜配合され
る。The poultice of the present invention is prepared by thoroughly kneading each of the above components with other appropriate ingredients to form a beinet-like poultice. It is used by applying it to a support (backing) such as a tech film, and covering it with a facing such as a polyethylene film if necessary. As other components of the present invention, any commonly used appropriate components may be used. For example, propylene glycol, polyethylene glycol, glycerin, sorbitol, etc.
Seeds or two or more polyhydric alcohols (composition 14°, usually 5 to 60 parts of the entire plaster. If it is less than 5 parts, the moisturizing effect will be insufficient, and the upper limit will especially include night, montmorillonite, zinc oxide, titanium oxide, anhydrous silicon. Inorganic powder containing one or more types of acids, etc. (compounding amount is usually 0 to 30%. If the amount is more than 30%, the paste becomes too hard and the fit and adhesion to the skin are low),
Water (compounding amount usually 10 to 80 parts. Methyl decaate, glycol salicylate, indomethacin, t-menthol,)
Tsuka oil, eucalyptus oil, dt-camphor, capsicum quince, nonylic acid vanillylamide, vitamin E1, diphenhydramine, chlorpheniramine maleate, thymol, etc. or 2 or more active ingredients (compounding amount usually 0 to 20
), and the physical properties of the paste (flexibility, adhesiveness, shape retention, etc.)
[As agents, guar gum, xanthan gum, gum arabic,
Starch derivatives, polybutene, latex, vinyl acetate emulsicone, y-ri-IJ-le-M fat emulsions and other molecular substances and active ingredients are appropriately blended according to the need for stable blending.
而して、本発明は、膏体がpH3,5〜6の酸性であり
、かつポリアクリル酸及び/又はポリアクリル酸塩とこ
れと異なる他の水溶性高分子物質とを互に異なる金属イ
オン種を有する多価金属塩で架橋させてなることを特徴
とするもので、これにより市が35〜6の酸性領域でも
ブレや裏じみが生じることがなく、せフζ酸性であるた
め有効成分か安定に配合されると丼に、皮膚刺激性も弱
いものであり、更にポリアクリル酸及び/又1dポリア
クリル酸塩の配合によって皮膚への粘着性の高いもので
ある。Therefore, the present invention provides that the plaster is acidic with a pH of 3.5 to 6, and that polyacrylic acid and/or polyacrylate and other water-soluble polymeric substances are mixed with different metal ions. It is characterized by being cross-linked with a polyvalent metal salt having seeds, and as a result, it does not cause blurring or bleeding even in the acidic range of 35 to 6. If it is stably blended, it will have low skin irritation, and if it is blended with polyacrylic acid and/or 1d polyacrylate, it will have high adhesion to the skin.
次に、実施例と比較例を示し、本発明を具体的に説明す
る。Next, the present invention will be specifically explained by showing Examples and Comparative Examples.
〔実施例1.比較例1〕 下記処方の湿布剤を下記製法に従って調製した。[Example 1. Comparative example 1] A poultice having the following formulation was prepared according to the following manufacturing method.
実施例1 比較例1
(1)ゼラチン 20
% 2.0係(3) 、j′?リアクリ人酸ソーダ(
アロンビスSS) 2.0 2.0(4
)カルボキシメチルセルロース(ダイセル1350)
2.0 2.0(5)ポリビニルピロリドン(K
−90) 2.0 2.0(6)グリセリン
20,0 20.0(7
)カオリン 10
10(8)有効成分 ザルチル酸グリコール
1.0 1.Ot−メントール 05
05dt−カンフル 0.5
Q、5ビタミンE O,5Q、5
(9)活性剤 ポリソルベー)80 ’0
.5 0.5(10水酸化カルシウム
0.2−旧)アンモニウム明パン10%水
溶液 3.0 5.0合計 100.0
係100.0%
〔製法〕
(1)を(12)に加温溶解し、これに(2) (7)
(8) (9)を加えて練合し、よく分散させる。次
に、これK(6)に(3) (4)(5) QQ (1
1)を加えてよく分散させたものを加え、均一に練合し
て4−7ト状の湿布剤骨休を得た。これヲ不織布土に塗
布し、ポリエチレンフィルムのクエイシングを施しそ。Example 1 Comparative Example 1 (1) Gelatin 20
% 2.0 section (3), j′? Liacrylic acid sodium (
Aronbis SS) 2.0 2.0 (4
) Carboxymethyl cellulose (Daicel 1350)
2.0 2.0(5) Polyvinylpyrrolidone (K
-90) 2.0 2.0(6) Glycerin 20.0 20.0(7
) Kaolin 10
10(8) Active ingredient Glycol salicylate
1.0 1. Ot-Menthol 05
05dt-camphor 0.5
Q,5 Vitamin E O,5Q,5
(9) Activator Polysorbate) 80'0
.. 5 0.5 (10 Calcium hydroxide
0.2-Old) Ammonium light bread 10% aqueous solution 3.0 5.0 Total 100.0
100.0% [Production method] Dissolve (1) in (12) by heating, and add (2) (7) to this.
(8) Add (9) and knead to disperse well. Next, to this K (6) (3) (4) (5) QQ (1
A well-dispersed mixture of 1) was added and kneaded uniformly to obtain a poultice in the form of 4 to 7 sheets. This was applied to non-woven soil and quasing with polyethylene film was applied.
上記実施例1の湿布剤は優れた粘着力(ン1?−ルタノ
クA;10 )を有し、捷た宵体のρI−1&、:f4
.’2前後であり、配合されたザルチル酸グリコール等
の有効成分は極めて安定であった。The poultice of Example 1 has excellent adhesion (n1?-Rutanok A;10), and when folded, the poultice has an excellent adhesive strength (ρI-1&, :f4)
.. The active ingredients such as glycol salicylate were extremely stable.
〔実施例2.比較f!12]
下記処方の湿布剤を下言C52法に従ってり、iE4!
した〔処方〕
実施例2 比軸例2
(1)ポリアクリル酸10係水溶液 30.0
係 300係(ジーリマ−ACIO3H)
(固形分3%)(2)ポリアクソノ9波ソーダ(アロン
ビス88) 1.6 1.6(3)カ
ルボキシメチルセルロース(ダイセル1350) 3
.0 30(4)アルギ2jソ〜ダ
0.5 0.5(5)カラヤガ゛
ム 1.0 1.
0(6)グリセリン 13.0
]、3.0(7)70%ソルビトール
10.0 ]、0.0(8)カオリン
10.0 10.0
(9)有効成分 ザルチル酸−リコール 10
]]OL−メントール 1.0 1.
0dl−力・ンフル 10 10ビタミン
E O,30,311()活性剤 ポ
リソルベー) 80 0.5 0.5
111)水酸化カルシウム 0.2−
(Lvステアリン酸アルミニウム 20
25合 言j 100.0% 1
00.0%〔製法〕
(1) (7) (8) (9) Oo) f13)を
混合し、よく攪拌して均一に分散略せる。次に、この分
散液に(6)に(2) (3) (4) (5) (+
1) (121を分散させたものを加えてよく練合し、
K〜ヌト状の湿布剤宵体を得る。これを不織布上に塗布
し、ポリエチレンフィルムのフエイシングf施しfc。[Example 2. Comparison f! 12] I applied the following prescription poultice according to the lower C52 method and used iE4!
[Prescription] Example 2 Ratio example 2 (1) Polyacrylic acid 10 aqueous solution 30.0
Section 300 (Zirimar-ACIO3H)
(Solid content 3%) (2) Polyaxono 9 wave soda (Aronbis 88) 1.6 1.6 (3) Carboxymethylcellulose (Daicel 1350) 3
.. 0 30 (4) Algi 2j Soda
0.5 0.5 (5) Karayagam 1.0 1.
0(6) Glycerin 13.0
], 3.0 (7) 70% sorbitol
10.0], 0.0(8) Kaolin
10.0 10.0
(9) Active ingredient salicylic acid-recall 10
]]OL-Menthol 1.0 1.
0dl-Power/Nfur 10 10 Vitamin E O, 30, 311 () Activator Polysorbate) 80 0.5 0.5
111) Calcium hydroxide 0.2-
(Lv aluminum stearate 20
25 Password j 100.0% 1
00.0% [Manufacturing method] (1) (7) (8) (9) Oo) f13) are mixed and stirred well to ensure uniform dispersion. Next, add (6) to (2) (3) (4) (5) (+
1) (Add 121 dispersed and mix well,
K ~ Obtain a sticky poultice. This was applied onto a nonwoven fabric, and a facing of polyethylene film was applied.
この実施例2の湿布剤は強い粘着力を有し、またpHは
4.6前後であり、有効成分の安定性に優れ、更に製造
工程中全く加熱を要しないため、揮散性有効成分(1−
メントール、dt−カンフル)の配合上極めて有用なも
のであった〇
〔実施例3.比較例3〕
下記処方の湿布剤を下記製法に従って調製した。The poultice of Example 2 has strong adhesive strength, has a pH of around 4.6, has excellent stability of the active ingredient, and does not require any heating during the manufacturing process, so the volatile active ingredient (1 −
It was extremely useful in blending menthol, dt-camphor) [Example 3. Comparative Example 3] A poultice having the following formulation was prepared according to the following manufacturing method.
実施例3 比較例3
(2)f!!J 7 り’J xfQ (シzンoンP
W−110) 2.0 2.0(3)ポリ
アクリル酸ソーダ(アロンビスSS) 2.0
2.0(4)カルボキシメナルセルロース(ダイセル
2200) 2.0 2.0(7)有効成分
ザルチル酸メチル 1.0 1.Ot
−メントール 1.0 ]、、0ノ
ニル酸ワニリルアミド 0.05 0.05
(8)活性剤 ポリソルベート80 0.
5 0.5(9)ステアリン酸マグネシウム
20 −(10)塩化第1錫5係水溶液
4,0 10.0(11)EDT
A −2ナトリウム 0.15
0.37合 計 100.0
壬 1000係〔製法〕
(1) <2)(6) (7) (8)α2)を混合し
て攪拌し、均一に分散させる。次に、この分散液に(5
)に(3) (4) (9)を分散させたものを加えて
よく練合し、ペースト状とする。Example 3 Comparative Example 3 (2) f! ! J 7 ri'J xfQ (Shi z on P
W-110) 2.0 2.0 (3) Sodium polyacrylate (Aronbis SS) 2.0
2.0 (4) Carboximenal cellulose (Daicel 2200) 2.0 2.0 (7) Active ingredient Methyl salicylate 1.0 1. Ot
-Menthol 1.0 ], 0 Nonylic acid vanillylamide 0.05 0.05
(8) Activator Polysorbate 80 0.
5 0.5(9) Magnesium stearate
20 - (10) Stannous chloride 5-containing aqueous solution 4,0 10.0 (11) EDT
A-2 Sodium 0.15
0.37 total 100.0
1000 [Manufacturing method] (1) <2) (6) (7) (8) α2) are mixed and stirred to uniformly disperse. Next, add (5
), add (3), (4), and (9) dispersed therein and mix well to form a paste.
これに(]0に(11)を溶解さぜた溶液を枕台下に加
えて9)に練合し、ペースト状の湿布剤膏体を得る。こ
れを不織布上に塗布し、ポリエチレンフィルムのフェイ
シングを施した。A solution prepared by dissolving (11) in (10) is added under the pillow bed and kneaded into 9) to obtain a paste-like poultice. This was applied onto a nonwoven fabric, and a polyethylene film facing was applied.
この実施例3の湿布剤はPH48前後であり、前記実施
例1.2と同様に優れた特性を有するものであった。The poultice of Example 3 had a pH of around 48, and had excellent properties similar to those of Example 1.2.
〔実施例4〕 下記処方の湿布剤を下記製法文従って調製した。[Example 4] A poultice having the following formulation was prepared according to the following manufacturing process.
(1)ゼラチン
20%)
(3)ホリ7 りI)klp(シュyaンPW−110
) 1.0(4)ポリアクリル酸ソ〜ダ(ア
ロンビスSS) 1.5(5)カルボキシメ
テルセルローヌ(ダイセルCMC1350)
3.0(6)カオリ7
10.0(7)グリセリン
20.0(8)有効成分 サルチル
酸グリコール ]]Ot−メント−ル
10dt−カンフル
10(9)活性剤 ポリソルベート80
05(11ステアリン酸マグネシウム
O5(1υジヒドロキシアルミニ
ウムアラントイネートo2(1,2+ 5%カリ明パン
溶液 1゜(13)水
残金
言1 100.0〔
製法〕
(1)(2) (3) (6) (8) (9) (1
31を攪拌、混合し、均一な分散液とする。次に、仁の
分散液に(4) (5)α0(11)α渇を(7)中に
分散させた溜液を加えて練合し、被−ヌト状の湿布剤膏
体を得る。これを実施例1〜3と同様にして湿布剤を得
た。(1) Gelatin
20%) (3) Hori 7 Ri) klp (Shuyan PW-110
) 1.0 (4) Sodium polyacrylate (Alonbis SS) 1.5 (5) Carboxymethel cellulone (Daicel CMC1350)
3.0 (6) Kaori 7
10.0(7) Glycerin
20.0(8) Active ingredient Glycol salicylate]]Ot-menthol
10dt-camphor
10(9) Activator Polysorbate 80
05 (11 Magnesium stearate
O5 (1υ dihydroxyaluminum allantoinate o2 (1,2+ 5% potassium bright pan solution 1° (13) water
Remaining amount
Word 1 100.0 [
Manufacturing method] (1) (2) (3) (6) (8) (9) (1
31 is stirred and mixed to form a uniform dispersion. Next, a stock solution containing (4) and (5) α0 (11) α-thin dispersed in (7) is added to the kernel dispersion and kneaded to obtain a poultice-like paste. A poultice was obtained in the same manner as in Examples 1 to 3.
この湿布剤も実施例1〜3と同様に優れた特性を有する
ものであった。This poultice also had excellent properties similar to Examples 1 to 3.
〔比較例4〕
下記処方の従来型湿布剤を下記製法に従って調ルIメジ
た。[Comparative Example 4] A conventional poultice having the following formulation was prepared according to the following manufacturing method.
(1)を加温してα0に溶解する。このゼラチン水溶液
中に(5) (6) (7)を加え均一に分散させる。(1) is heated and dissolved in α0. Add (5), (6), and (7) into this aqueous gelatin solution and disperse uniformly.
次いで、これにあらかじめ(4)に(2) (3)を分
散させたものを加え均一に練合する。最後に(9)に(
8)をg解した溶液を加えてさらに練合し、ペースト状
としたものを不織布上に塗布し、表面にポリエチレンフ
づルムの7エイシングを施した。このものの何体表面P
Hは約8.5であった。Next, a pre-dispersed mixture of (4), (2), and (3) is added to this mixture and kneaded uniformly. Finally, in (9) (
8) was added and further kneaded to form a paste, which was applied onto a nonwoven fabric, and the surface was coated with polyethylene film. What is the surface of this thing?
H was about 8.5.
次に上記実施例1〜3、比較例1〜3の湿布剤及び比較
例4の従来型湿布剤を用い、それらの次しみ出し及び有
効成分安定性を調べた。この場合、汰しみ出しはサンプ
ルのポリエチレンフィルムを被覆した側を上にしてその
上に10 ff / Qn”の圧をかけて室泥で一週間
放置し、支持体の裏から膏体又はその構成成分の一部が
しみ出したか否かを官能評価し、有効成分安定性はサン
プルを80℃で3日間保存し、保存後のサルチル酸エス
テルの残存率を求めた。結果を表に示す。なお裏しみ出
し及び有効成分安定性の評価基準は下記の通りである。Next, using the poultices of Examples 1 to 3, Comparative Examples 1 to 3, and the conventional poultice of Comparative Example 4, their subsequent exudation and stability of active ingredients were investigated. In this case, to remove the ooze, place the sample with the polyethylene film-covered side facing up, apply a pressure of 10 ff/Qn, and leave it in room mud for a week, and remove the plaster or its composition from the back of the support. A sensory evaluation was performed to determine whether or not a part of the ingredient oozed out, and the stability of the active ingredient was determined by storing the sample at 80°C for 3 days and determining the residual rate of salicylic acid ester after storage.The results are shown in the table. The evaluation criteria for back seepage and active ingredient stability are as follows.
表
※裏しみ出し評価基準
○:しみ出し全く無し
×:〃 有シ
××:〃 著しく多く有り
表の結果よシ、2釉以上の多価金属を併用することによ
り、裏しみ出しが生じない優れた酸性の湿布剤が得られ
ることが知見された。Front * Back seepage evaluation criteria ○: No seepage at all It has been found that an excellent acidic poultice is obtained.
出願人 ライオン株式会社 代理人 弁理士 小 島 隆 司 122Applicant Lion Corporation Agent: Patent Attorney Takashi Kojima 122
Claims (1)
クリル酸及び/又はポリアクリル酸塩とこれと異なる他
の水溶性高分子物質とを互に異なる金属イオン科を有す
る多価金属塩でそれぞれ架橋させてなることを4¥宿と
する湿布剤。 2 仙の水溶性高分子物質がゼラチン、ペクチン、セル
ロース6導体、アルギン酸塩、ポリビニルアルコール、
メチルビニルエーテル・無水マレイン酸共重合体の中か
ら選ばれる1 ai又は2秤以上のものである特許gt
f求の訃、囲第1項記如゛の湿布°剤0 3、 互にrAなる金靭イオン釉を有する多佃1金属塩
の糾合せが、Ca1fiとp、を塩、Ca塩とFej3
、Mg塩とFe堪、Ca塩とSn塩、Mg塩とSn塩又
はMg塩とAt塩である特許請求の範囲第1項又は第2
勇記載の湿布剤。[Scope of Claims] 1. The plaster is acidic with a pH of 3.5 to 6, and the polyacrylic acid and/or polyacrylate and other water-soluble polymer substances are made of different metals. A poultice made by cross-linking with polyvalent metal salts having ionic properties. 2 Sen's water-soluble polymer substances include gelatin, pectin, cellulose 6 conductor, alginate, polyvinyl alcohol,
Patent gt that is 1 ai or 2 or more selected from methyl vinyl ether/maleic anhydride copolymer
The death of f, the poultice as described in the first section of the box 03, the combination of Tatsukuda 1 metal salts each having a tough ionic glaze of rA, Ca1fi and p, salt, Ca salt and Fej3
, Mg salt and Fe salt, Ca salt and Sn salt, Mg salt and Sn salt, or Mg salt and At salt, claim 1 or 2.
A poultice written by Yu.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22158882A JPS59110616A (en) | 1982-12-17 | 1982-12-17 | Poultice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22158882A JPS59110616A (en) | 1982-12-17 | 1982-12-17 | Poultice |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59110616A true JPS59110616A (en) | 1984-06-26 |
JPH0333686B2 JPH0333686B2 (en) | 1991-05-20 |
Family
ID=16769097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22158882A Granted JPS59110616A (en) | 1982-12-17 | 1982-12-17 | Poultice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59110616A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63150222A (en) * | 1986-12-12 | 1988-06-22 | Nippon Junyaku Kk | Poultice |
JPS63254180A (en) * | 1987-04-09 | 1988-10-20 | Kobayashi Kooc:Kk | Antioxidant composition |
JPH03123727A (en) * | 1989-10-04 | 1991-05-27 | Nitto Denko Corp | Percutaneous absorption preparation |
FR2734574A1 (en) * | 1995-05-24 | 1996-11-29 | Pacific Corp | Adhesive formulation for cosmetic and medical use |
US5872161A (en) * | 1997-03-27 | 1999-02-16 | The Procter & Gamble Company | Denture adhesive compositions |
US5877233A (en) * | 1997-03-27 | 1999-03-02 | The Proctor & Gamble Company | Denture adhesive compositions |
JP2016519058A (en) * | 2013-03-13 | 2016-06-30 | エーブリー デニソン コーポレイション | Improved adhesive properties |
JPWO2016104226A1 (en) * | 2014-12-22 | 2017-09-28 | 久光製薬株式会社 | Poultice |
-
1982
- 1982-12-17 JP JP22158882A patent/JPS59110616A/en active Granted
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63150222A (en) * | 1986-12-12 | 1988-06-22 | Nippon Junyaku Kk | Poultice |
JPH0794383B2 (en) * | 1986-12-12 | 1995-10-11 | 日本純薬株式会社 | Patch agent |
JPS63254180A (en) * | 1987-04-09 | 1988-10-20 | Kobayashi Kooc:Kk | Antioxidant composition |
JPH0781139B2 (en) * | 1987-04-09 | 1995-08-30 | 株式会社コーセー | Antioxidant composition |
JPH03123727A (en) * | 1989-10-04 | 1991-05-27 | Nitto Denko Corp | Percutaneous absorption preparation |
FR2734574A1 (en) * | 1995-05-24 | 1996-11-29 | Pacific Corp | Adhesive formulation for cosmetic and medical use |
US5872161A (en) * | 1997-03-27 | 1999-02-16 | The Procter & Gamble Company | Denture adhesive compositions |
US5877233A (en) * | 1997-03-27 | 1999-03-02 | The Proctor & Gamble Company | Denture adhesive compositions |
JP2016519058A (en) * | 2013-03-13 | 2016-06-30 | エーブリー デニソン コーポレイション | Improved adhesive properties |
US11717593B2 (en) | 2013-03-13 | 2023-08-08 | Avery Dennison Corporation | Improving adhesive properties |
JPWO2016104226A1 (en) * | 2014-12-22 | 2017-09-28 | 久光製薬株式会社 | Poultice |
JP2020063303A (en) * | 2014-12-22 | 2020-04-23 | 久光製薬株式会社 | Poultice |
JP2022016703A (en) * | 2014-12-22 | 2022-01-21 | 久光製薬株式会社 | Cataplasms |
Also Published As
Publication number | Publication date |
---|---|
JPH0333686B2 (en) | 1991-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2735392B2 (en) | How to treat psoriasis | |
DE69325495T2 (en) | Extrudable compositions for topical or transdermal drug delivery | |
DE3851100T2 (en) | Process for the production of a plaster with a hydrophilic acrylate adhesive layer. | |
CN111615381B (en) | Pharmaceutical composition for transdermal administration in the form of a hydrogel patch | |
WO2006090782A1 (en) | Composition for hydrous adhesive patch for external use and adhesive patch comprising the composition | |
TWI513479B (en) | Water-based patch | |
JPH08188527A (en) | Sheet-like pack agent | |
JPS59110616A (en) | Poultice | |
HU205013B (en) | Process for producing surface therapy plaster containing 5-fluor-uracil | |
JPS6034924B2 (en) | Poultice and its manufacturing method | |
JPH08319213A (en) | Self-adhesive pack sheet for beauty and medical treatment | |
TWI451884B (en) | Butenafine hydrochloride containing hydrophilic patch | |
JPH0339043B2 (en) | ||
JPS6112614A (en) | Drug for external use | |
JP3193161B2 (en) | Transdermal absorption preparation | |
JPS60260513A (en) | Poultice | |
JPS59110614A (en) | Preparation of poultice | |
WO2021161895A1 (en) | Production method for adhesive layer composition for production of cooling sheet, production method for cooling sheet, and cooling sheet | |
JP2017226609A (en) | Water-containing gel composition | |
JPH0555485B2 (en) | ||
JPS6116369B2 (en) | ||
JPH0794383B2 (en) | Patch agent | |
JP2887548B2 (en) | Hydrous skin external patch with improved usability | |
JP3478865B2 (en) | Hydrogel plaster | |
JPH0338245B2 (en) |